CAM
RMD icon

Carret Asset Management’s ResMed RMD Stock Holding History

Carret Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$928K Buy
4,760
+1,380
+41% +$286K 0.08% 161
2026
Q1 		$759K Buy
3,380
+10
+0.3% +$2.49K 0.07% 169
2025
Q4 		$812K Buy
+3,370
New +$862K 0.08% 167

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Carret Asset Management's RMD Position: Q2 2026 in Review

Carret Asset Management increased its ResMed (RMD) stake by 41% in Q2 2026, buying an estimated $286K and bringing the position to 4,760 shares worth $928K. The position accounts for 0.08% of the portfolio, ranked #161.

Carret Asset Management first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Carret Asset Management held 4,760 shares of ResMed worth $928K as of Q2 2026.
  • Carret Asset Management bought 1,380 ResMed shares in Q2 2026, an estimated $286K.
  • ResMed made up 0.08% of Carret Asset Management's portfolio in Q2 2026, its #161 holding.
  • Carret Asset Management first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Carret Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.